17-39729130-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_032339.5(MIEN1):c.*392G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0282 in 219,790 control chromosomes in the GnomAD database, including 134 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.028 ( 87 hom., cov: 32)
Exomes 𝑓: 0.029 ( 47 hom. )
Consequence
MIEN1
NM_032339.5 3_prime_UTR
NM_032339.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.103
Genes affected
MIEN1 (HGNC:28230): (migration and invasion enhancer 1) Involved in negative regulation of apoptotic process; positive regulation of cell migration; and positive regulation of filopodium assembly. Located in several cellular components, including centriolar satellite; cytosol; and nucleoplasm. Is intrinsic component of the cytoplasmic side of the plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
ERBB2 (HGNC:3430): (erb-b2 receptor tyrosine kinase 2) This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0278 (4232/152210) while in subpopulation NFE AF = 0.0424 (2882/68018). AF 95% confidence interval is 0.0411. There are 87 homozygotes in GnomAd4. There are 2035 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 87 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0278 AC: 4232AN: 152092Hom.: 87 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4232
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0292 AC: 1976AN: 67580Hom.: 47 Cov.: 0 AF XY: 0.0280 AC XY: 994AN XY: 35490 show subpopulations
GnomAD4 exome
AF:
AC:
1976
AN:
67580
Hom.:
Cov.:
0
AF XY:
AC XY:
994
AN XY:
35490
Gnomad4 AFR exome
AF:
AC:
11
AN:
1976
Gnomad4 AMR exome
AF:
AC:
104
AN:
4012
Gnomad4 ASJ exome
AF:
AC:
19
AN:
1894
Gnomad4 EAS exome
AF:
AC:
6
AN:
4404
Gnomad4 SAS exome
AF:
AC:
152
AN:
8960
Gnomad4 FIN exome
AF:
AC:
102
AN:
1932
Gnomad4 NFE exome
AF:
AC:
1476
AN:
40448
Gnomad4 Remaining exome
AF:
AC:
105
AN:
3638
Heterozygous variant carriers
0
94
188
283
377
471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0278 AC: 4232AN: 152210Hom.: 87 Cov.: 32 AF XY: 0.0274 AC XY: 2035AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
4232
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
2035
AN XY:
74400
Gnomad4 AFR
AF:
AC:
0.00729453
AN:
0.00729453
Gnomad4 AMR
AF:
AC:
0.0199503
AN:
0.0199503
Gnomad4 ASJ
AF:
AC:
0.0106751
AN:
0.0106751
Gnomad4 EAS
AF:
AC:
0.00116009
AN:
0.00116009
Gnomad4 SAS
AF:
AC:
0.0174491
AN:
0.0174491
Gnomad4 FIN
AF:
AC:
0.0515192
AN:
0.0515192
Gnomad4 NFE
AF:
AC:
0.0423711
AN:
0.0423711
Gnomad4 OTH
AF:
AC:
0.0236742
AN:
0.0236742
Heterozygous variant carriers
0
215
430
646
861
1076
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at